Predicting prognosis in castration-resistant prostate cancer

被引：0
|
作者：
机构：
来源：
Nature Reviews Cancer | 2012年 / 12卷 / 11期
关键词：
D O I：
10.1038/nrc3391
中图分类号：
学科分类号：
摘要：
Two prospective studies reported inThe Lancet Oncologyhave shown that mRNA expression signatures from whole blood can be used to stratify patients with castration-resistant prostate cancer into high- and low-risk groups.
引用
收藏
页码：736 / 736
相关论文
共 50 条
  • [21] Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
    Danila, Daniel C.
    Heller, Glenn
    Gignac, Gretchen A.
    Gonzalez-Espinoza, Rita
    Anand, Aseem
    Tanaka, Erika
    Lilja, Hans
    Schwartz, Lawrence
    Larson, Steven
    Fleisher, Martin
    Scher, Howard I.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7053 - 7058
  • [22] Contemporary molecular tests for prognosis and treatment guidance for castration-resistant prostate cancer
    Buonerba, Carlo
    Di Lorenzo, Giuseppe
    Sonpavde, Guru
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (10) : 1113 - 1120
  • [23] Raman spectroscopy, a potential tool in diagnosis and prognosis of castration-resistant prostate cancer
    Wang, Lei
    He, Dalin
    Zeng, Jin
    Guan, Zhenfeng
    Dang, Qiang
    Wang, Xinyang
    Wang, Jun
    Huang, Liqing
    Cao, Peilong
    Zhang, Guanjun
    Hsieh, JerTong
    Fan, Jinhai
    [J]. JOURNAL OF BIOMEDICAL OPTICS, 2013, 18 (08)
  • [24] Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer
    Giridhar, Karthik V.
    Sanhueza, Cristobal
    Hillman, David W.
    Alkhateeb, Hassan
    Carlson, Rachel
    Tan, Winston
    Costello, Brian A.
    Quevedo, Fernando
    Pagliaro, Lance
    Kohli, Manish
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (03) : 431 - 437
  • [25] Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer
    Karthik V. Giridhar
    Cristobal Sanhueza
    David W Hillman
    Hassan Alkhateeb
    Rachel Carlson
    Winston Tan
    Brian A. Costello
    Fernando Quevedo
    Lance Pagliaro
    Manish Kohli
    [J]. Prostate Cancer and Prostatic Diseases, 2018, 21 : 431 - 437
  • [26] A microRNA classifier for predicting neuroendocrine differentiation in castration-resistant prostate cancer patients
    Saini, Sharanjot
    Sreekumar, Amritha
    Lee, Jin Tae
    Patel, Nikhil
    Sharma, Ashok
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [27] Biomarkers in Metastatic Castration-resistant Prostate Cancer
    Miller, K.
    [J]. AKTUELLE UROLOGIE, 2015, 46 (01) : 66 - 70
  • [28] The DNA methylome of castration-resistant prostate cancer
    Kleb, Brittney N.
    Estecio, Marcos
    Zhang, Jiexin
    Tzelepi, Vasso
    Chung, Woonbok
    Maity, Sankar
    Logothetis, Christopher
    Troncoso, Patricia
    Navone, Nora
    Jelinek, Jaroslav
    Liang, Shoudan
    Issa, Jean-Pierre
    Aparicio, Ana
    [J]. CANCER RESEARCH, 2012, 72
  • [29] Castration-Resistant Prostate Cancer: AUA Guideline
    Cookson, Michael S.
    Roth, Bruce J.
    Dahm, Philipp
    Engstrom, Christine
    Freedland, Stephen J.
    Hussain, Maha
    Lin, Daniel W.
    Lowrance, William T.
    Murad, Mohammad Hassan
    Oh, William K.
    Penson, David F.
    Kibel, Adam S.
    [J]. JOURNAL OF UROLOGY, 2013, 190 (02): : 429 - 438
  • [30] Olaparib in metastatic castration-resistant Prostate Cancer
    Lorenz, Judith
    [J]. AKTUELLE UROLOGIE, 2022, 53 (02)
12345